A Fresh Look at Pharma
By Erica Garcia

(MONEY Magazine) – Last spring regulators made the big brokerages agree to provide more independent stock research to customers. So where might Wall Street find some new insights? Would you believe India, by way of northeast Pennsylvania? Scranton's Life Science Analytics takes a page from the tech biz and uses workers in Hyderabad to collect news and data on health-care firms. Computers back home assign stocks scores for 30 key attributes. Among LSA's most revealing stats is the Total Clinical Index (TCI), which tracks the number of new drugs a company is developing and their chances of getting to market. Above, we've listed the four Big Pharma firms with the fattest pipelines, according to LSA. --ERICA GARCIA